RONALD VINCENT: Open Payments
NPI 1851994008 · FARMINGTON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$777 in 38 payments from 10 companies in 2025. Trend: 2023 $765 · 2024 $894 · 2025 $777
Food & beverage: $777
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $356 |
| AstraZeneca Pharmaceuticals LP | 9 | $159 |
| GlaxoSmithKline, LLC. | 3 | $49 |
| Exact Sciences Corporation | 2 | $48 |
| Lilly USA, LLC | 3 | $43 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $42 |
| ABBVIE INC. | 1 | $25 |
| Boston Scientific Corporation | 1 | $22 |
| ALK-Abello, Inc | 1 | $17 |
| Astellas Pharma US Inc | 1 | $14 |
Products named: Ozempic, AIRSUPRA, Rybelsus, TRELEGY ELLIPTA, Cologuard Collection Kit, MOUNJARO, OFEV, UBRELVY.
Industry payments across MI — which companies pay providers there.
